Showing results 1 to 6 of 6
Title | Author(s) | Issue Date | |
---|---|---|---|
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines Journal:Investigational New Drugs | 2013 | ||
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma Journal:Cancer Chemotherapy and Pharmacology | 2013 | ||
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma Journal:Investigational New Drugs | 2011 | ||
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines Journal:Investigational New Drugs | 2013 | ||
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models Journal:Cancer Letters | 2014 | ||
The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines Journal:Investigational New Drugs | 2010 |